Implantable cardioverter/defibrillator and method employing cross-phase spectrum analysis for arrhythmia detection

• US 5,292,348 A
• Filed: 04/13/1992
• Issued: 03/08/1994
• Est. Priority Date: 06/14/1991
• Status: Expired due to Term

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Original Assignee: Telectronics Pacing Systems, Inc (Abbott Laboratories)
• Inventors: Saumarez, Richard, Murphy, Anthony
• Primary Examiner(s): Cohen, Kee S.
• Assistant Examiner(s): Jastrzab, Jeffrey R.
• Application Number:
  US07/867,835
• Time in Patent Office: 694 Days
• Field of Search: 128/419 D, 128/419 PG, 607/5, 607/14
• US Class Current: 607/5
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

A method and apparatus for detecting and reverting pathological heart rhythms of a patient are disclosed. A plurality of electrical heart rhythm signals of the patient are sensed at two different locations within the heart. The cross-phase spectra of the sensed heart rhythm signals for each heartbeat are calculated and such heart rhythms are classified based upon the information contained in the cross-phase spectra. Appropriate therapy is then delivered to the patient'"'"'s heart to revert those of the heart rhythms that are classified as pathological.

Claims

1. A method of detecting and reverting pathological heart rhythms of a patient, comprising the steps of:

sensing each of a plurality of electrical heart rhythm signals of the patient at two different locations;

calculating cross-phase spectra of sensed heart rhythm signals;

classifying the heart rhythms based upon information contained in said cross-phase spectra; and

,

delivering appropriate therapy to the patient'"'"'s heart to revert heart rhythms classified as pathological.

2. A method according to claim 1, wherein said sensing step includes the sub-step of sensing electrical heart rhythm signals at two different locations within the heart.

3. A method according to claim 2, wherein said therapy delivering step includes the sub-step of delivering anti-tachycardia pacing therapy to the heart to revert pathological ventricular tachycardia.

4. A method according to claim 2, wherein said therapy deliverying step includes the sub-step of delivering defibrillation shock therapy to the heart to revert ventricular fibrillation.

5. Apparatus for detecting and reverting pathological heart rhythms of a patient, comprising:

means for sensing each of a plurality of electrical heart rhythm signals of the patient at two different locations;

means for calculating cross-phase spectra of the sensed heart rhythm signals;

means for classifying heart rhythms based upon information contained in said cross-phase spectra; and

,

means for delivering appropriate therapy to the patient'"'"'s heart to revert heart rhythms classified as pathological.

6. Apparatus according to claim 5, wherein said sensing means senses said heart rhythm signals at two different locations within the heart.

7. Apparatus according to claim 6, wherein said therapy delivering means delivers anti-tachycardia pacing therapy to the heart to revert pathological ventricular tachycardia.

8. Apparatus according to claim 6, wherein said therapy delivering means delivers defibrillation shock therapy to the heart to revert ventricular fibrillation.

9. Apparatus according to any one of claims 6-8, wherein said sensing means includes at least 2 pairs of bipolar sensing electrodes, each of said pairs of sensing electrodes serving to sense each of said heart rhythm signals at one of said two locations within the heart.

10. Apparatus according to claim 9, wherein said apparatus further includes an endocardial lead, and wherein said two pairs of bipolar sensing electrodes include three electrodes positioned at spaced apart locations on a distal portion of said endocardial lead, one of said three electrodes serving as a common electrode for both of said two pairs of bipolar sensing electrodes.

11. Apparatus according to claim 9, wherein said apparatus further includes two endocardial leads, and wherein each of said two pairs of bipolar sensing electrodes includes two electrodes positioned on a distal portion of a corresponding one of said endocardial leads which is other than the endocardial lead that carries the two electrodes of the other of said two pairs of bipolar sensing electrodes.

12. Apparatus according to any one of claims 6-8, wherein said calculating means includes means for selectively performing Fast Fourier Transforms of the heart rhythm signals that are sensed for each heartbeat at said two locations within the heart.

13. Apparatus according to claim 12, wherein said classifying means includes averaging means for calculating an average cross-phase spectrum over a number of successive heart beats, and comparator means for comparing a cross-phase spectrum from a current heartbeat with said average cross-phase spectrum to determine whether said current heartbeat is a normal heartbeat or an abnormal heartbeat.

14. Apparatus according to claim 13, wherein said classifying means includes means for generating signals corresponding to physiological and pathological heartbeats, and further including microprocessor means responsive to said signals generated by said classifying means and coupled to said therapy delivering means for actuating said therapy delivering means ot deliver said therapy to the patient'"'"'s heart upon receiving signals from said classifying means that correspond to pathological heartbeats.

15. Apparatus according to claim 14, wherein said sensing means includes at least 2 pairs of bipolar sensing electrodes, each of said pairs of sensing electrodes serving to sense each of said heart rhythm signals at one fo said two locations within the heart.

16. Apparatus according to claim 15, wherein said apparatus further includes an endocardial lead, and wherein said two paris of bipolar sensing electrodes include three electrodes positioned at spaced apart locations on a distal portion of said endocardial lead, one of said three electrodes serving as a common electrode for both of said two pairs of bipolar sensing electrodes.

17. Apparatus according to cliam 15, wherein said apparatus includes two endocardial leads, and wherein each of said two paris of bipolar sensing electrodes includes two electrodes positioned on a distal portion of a corresponding one of said endocardial leads which is other than the endocardial lead that carries the two electrodes of the other of said two pairs of bipolar sensing electrodes.